Prostacyclin analogue (OP-2507) attenuates hepatic microcirculatory derangement, energy depletion, and lipid peroxidation in a rat model of reperfusion injury
Hm. Chen et al., Prostacyclin analogue (OP-2507) attenuates hepatic microcirculatory derangement, energy depletion, and lipid peroxidation in a rat model of reperfusion injury, J SURG RES, 80(2), 1998, pp. 333-338
Background Microcirculatory derangement, energy depletion, and lipid peroxi
dation are associated with the development of ischemia-reperfusion injury i
n the liver. This study investigated the effects of a prostacyclin analogue
(OP-2507) on hepatic ischemia-reperfusion injury. Materials and Methods. A
dult, male Sprague-Dawley rats were divided into four treatment groups: (1)
sham-operated control (laparotomy only, no ischemia), N =6; (2) ischemia c
ontrol (1 h ischemia, 2 h reperfusion), N = 6; (3) intravenous infusion wit
h OP-2507 ([15-cis-14-propylcyclohexyl]-16,17,18,19,20-pentanor-9-deoxy-9a,
6-nitrilo-PGF, methyl ether; Ono Pharmaceutical Co, Ltd, Osaka, Japan) at a
dose of 1 mu g/kg/min plus ischemia (1 h ischemia, 2 h reperfusion), N = 6
; and (4) intravenous infusion with OP-2507 at a dose of 0.1 mu g/kg/min pl
us ischemia (1 h ischemia, 2 h reperfusion), N = 6, A laser-Doppler flowmet
er and in vivo microscopy were used to investigate hepatic microcirculation
, Tissue malondialdehyde (MDA) and adenosine triphosphate (ATP) levels were
determined at the end of the experiment. Results. Compared with ischemia a
lone, OP-2507 significantly reduced the extent of microcirculatory and hemo
dynamic derangement following ischemia-reperfusion. The changes of mean sys
tolic arterial pressure (MSAP) following ischemia-reperfusion showed biphas
ic alterations. OP-2507 at both doses significantly attenuated decreases in
MSAP. OF-2507 lessened adherent leukocyte count and improved flow velocity
in the sinusoids and postsinusoidal venules, OF-2507 at the dose of I mu g
/kg/min reduced MDA (1.04 +/- 0.27 mu mol/g protein vs 2.64 +/- 0.59 mu mol
/g protein in the ischemia and reperfusion group) and increased ATP levels
(2.03 +/- 0.17 mu mol/g wet wt vs 0.73 +/- 0.21 mu mol/g wet wt in the isch
emia and reperfusion group), while OF-2507 at a smaller dose (0.1 mu g/kg/m
in) had lesser but significant effects on MDA and ATP alterations. Conclusi
on. This study demonstrates that OP-2507 treatment of ischemia can ameliora
te ischemia-reperfusion injury of the rat liver. (C) 1998 Academic Press.